Kyongbo Pharmaceutical Co Ltd
KRX:214390
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Kyongbo Pharmaceutical Co Ltd
Cash from Financing Activities
Kyongbo Pharmaceutical Co Ltd
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Kyongbo Pharmaceutical Co Ltd
KRX:214390
|
Cash from Financing Activities
₩33.8B
|
CAGR 3-Years
72%
|
CAGR 5-Years
50%
|
CAGR 10-Years
5%
|
|
|
Yuhan Corp
KRX:000100
|
Cash from Financing Activities
₩8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-18%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Cash from Financing Activities
-₩156.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Cash from Financing Activities
-₩97.2B
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Cash from Financing Activities
₩22.8B
|
CAGR 3-Years
20%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Cash from Financing Activities
-₩31.2B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Kyongbo Pharmaceutical Co Ltd
Glance View
KYONGBO PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Asan, Chungcheongnam-Do. The company went IPO on 2015-06-29. The firm distributes its products within domestic market and to overseas markets including China Japan and Europe.
See Also
What is Kyongbo Pharmaceutical Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
33.8B
KRW
Based on the financial report for Dec 31, 2025, Kyongbo Pharmaceutical Co Ltd's Cash from Financing Activities amounts to 33.8B KRW.
What is Kyongbo Pharmaceutical Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
5%
Over the last year, the Cash from Financing Activities growth was 143%. The average annual Cash from Financing Activities growth rates for Kyongbo Pharmaceutical Co Ltd have been 72% over the past three years , 50% over the past five years , and 5% over the past ten years .
